CSDX
CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant product; and CS-Protect Hydrogel, a tissue spacer gel for use in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Neuss, Germany.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q4 | 0.00 | -$94,200 | -$500M |
| 2025 Q3 | 0.00 | $23,050 | -$183 |
| 2025 Q2 | 0.00 | $730 | $500M |
| 2025 Q1 | 0.00 | $70,420 | $50,890 |
| 2024 Q3 | 0.00 | $7,964 | — |
| 2024 Q2 | 0.00 | $45,159 | — |
| 2024 Q1 | 0.00 | $53,258 | — |
| 2023 Q4 | -0.00 | $49,538 | -$500M |